Mirum Pharmaceuticals (MIRM) Short Interest Ratio & Short Volume → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free MIRM Stock Alerts $25.47 -0.75 (-2.86%) (As of 05/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Mirum Pharmaceuticals Short Interest DataCurrent Short Interest8,500,000 sharesPrevious Short Interest8,580,000 sharesChange Vs. Previous Month-0.93%Dollar Volume Sold Short$213.44 millionShort Interest Ratio17.4 Days to CoverLast Record DateApril 30, 2024Outstanding Shares47,130,000 sharesPercentage of Shares Shorted18.04%Today's Trading Volume502,209 sharesAverage Trading Volume527,566 sharesToday's Volume Vs. Average95% Short Selling Mirum Pharmaceuticals ? Sign up to receive the latest short interest report for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMIRM Short Interest Over TimeMIRM Days to Cover Over TimeMIRM Percentage of Float Shorted Over Time Ad Colonial MetalsWARNING about the death of the U.S. dollar…Where do you turn during times of economic uncertainty? Many elites trust storing their wealth in gold (which has historically boomed when the dollar’s value has plummeted!)Get Colonial Metals' new Precious Metals Investment Guide. Mirum Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20248,500,000 shares $213.44 million -0.9%N/A17.4 $25.11 4/15/20248,580,000 shares $205.15 million +5.2%N/A17.2 $23.91 3/31/20248,160,000 shares $204.98 million +0.3%N/A13.9 $25.12 3/15/20248,140,000 shares $217.91 million +6.3%N/A13.5 $26.77 2/29/20247,660,000 shares $219.92 million -1.5%N/A11.9 $28.71 2/15/20247,780,000 shares $225.46 million -0.9%N/A11.9 $28.98 Get the Latest News and Ratings for MIRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mirum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20247,850,000 shares $207.71 million +8.0%N/A11.6 $26.46 1/15/20247,270,000 shares $198.40 million +0.6%N/A10.8 $27.29 12/31/20237,230,000 shares $213.43 million +4.2%N/A12.1 $29.52 12/15/20236,940,000 shares $242.41 million +12.5%N/A12.3 $34.93 11/30/20236,170,000 shares $197.87 million -3.0%N/A11.2 $32.07 11/15/20236,360,000 shares $193.09 million +4.6%N/A12.2 $30.36 10/31/20236,080,000 shares $166.77 million -2.6%22.6%12.4 $27.43 10/15/20236,240,000 shares $175.47 million +4.9%24.7%12.3 $28.12 9/30/20235,950,000 shares $188.02 million +8.2%23.5%10.2 $31.60 9/15/20235,500,000 shares $180.68 million +8.3%21.8%9.4 $32.85 8/31/20235,080,000 shares $134.26 million +0.6%20.2%9 $26.43 8/15/20235,050,000 shares $129.73 million +24.7%18.7%9.4 $25.69 7/31/20234,050,000 shares $104.33 million +35.0%14.9%7.5 $25.76 7/15/20233,000,000 shares $78.75 million -8.0%11.1%5.7 $26.25 6/30/20233,260,000 shares $84.34 million +10.1%12.1%5.3 $25.87 6/15/20232,960,000 shares $83.15 million +0.7%11.0%5.1 $28.09 5/31/20232,940,000 shares $77.12 million -7.3%11.8%5.6 $26.23 5/15/20233,170,000 shares $82.52 million +1.6%12.7%6.4 $26.03 4/30/20233,120,000 shares $83.77 million +4.4%13.0%6.6 $26.85 4/15/20232,990,000 shares $74.72 million +69.9%12.5%6.3 $24.99 3/31/20231,760,000 shares $42.28 million -10.2%7.2%4.5 $24.02 3/15/20231,960,000 shares $46.31 million +7.1%8.0%6.5 $23.63 2/28/20231,830,000 shares $43.02 million -2.7%7.7%5.7 $23.51 2/15/20231,880,000 shares $42.41 million +14.6%7.9%5.6 $22.56 1/31/20231,640,000 shares $38.51 million +42.6%7.1%4.5 $23.48 1/15/20231,150,000 shares $25.30 million +9.5%4.9%3.2 $22.00 12/30/20221,050,000 shares $20.48 million -13.2%4.5%2.8 $19.50 12/15/20221,210,000 shares $21.62 million -18.8%5.3%3.1 $17.87 11/30/20221,490,000 shares $27.79 million -11.8%6.6%3.7 $18.65 11/15/20221,690,000 shares $33.85 million -8.2%7.4%4.3 $20.03 10/31/20221,840,000 shares $41.49 million -10.2%8.2%4.4 $22.55 10/15/20222,050,000 shares $39.20 million -18.3%9.2%5 $19.12 9/30/20222,510,000 shares $52.74 million +6.4%11.2%6.6 $21.01 9/15/20222,360,000 shares $54.09 million +0.9%10.5%7.1 $22.92Truth about Trump you’ve never heard (Ad)Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here. 8/31/20222,340,000 shares $58.45 million +8.3%11.4%7.9 $24.98 8/15/20222,160,000 shares $55.58 million +1.9%10.6%7.5 $25.73 7/31/20222,120,000 shares $53.21 million +0.5%11.5%8.1 $25.10 7/15/20222,110,000 shares $50.91 million +5.0%11.7%9.2 $24.13 6/30/20222,010,000 shares $39.11 million +21.8%11.1%8.8 $19.46 6/15/20221,650,000 shares $31.17 million +16.2%9.2%7.3 $18.89 5/31/20221,420,000 shares $33.21 million +67.9%7.9%7.4 $23.39 5/15/2022846,000 shares $20.30 million +13.7%4.7%4.7 $24.00 4/30/2022744,300 shares $17.70 million +14.0%4.1%4.3 $23.78 4/15/2022653,000 shares $17.96 million +19.8%3.6%3.6 $27.50 3/31/2022545,100 shares $12.00 million -27.2%3.2%3 $22.02 3/15/2022748,800 shares $16.21 million +55.7%4.4%4.3 $21.65 2/28/2022480,900 shares $11.40 million +2.7%2.9%2.9 $23.70 2/15/2022468,200 shares $10.28 million -18.1%2.8%2.8 $21.95 1/31/2022571,900 shares $10.89 million +20.3%3.5%3.5 $19.05 1/15/2022475,500 shares $8.91 million +5.2%2.8%3.5 $18.74 12/31/2021452,100 shares $7.21 million -0.5%2.7%3.3 $15.95 12/15/2021454,400 shares $6.65 million +10.3%2.7%2 $14.63 11/30/2021411,800 shares $5.86 million +13.6%2.5%1.8 $14.23 11/15/2021362,600 shares $5.62 million -19.9%2.2%1.6 $15.49 10/29/2021452,400 shares $7.18 million -3.6%2.7%2.2 $15.88 10/15/2021469,300 shares $8.03 million -2.1%3.1%2.3 $17.12 9/30/2021479,200 shares $9.55 million +17.3%3.1%2.6 $19.92 9/15/2021408,400 shares $7.53 million -11.6%2.6%3.9 $18.43 8/31/2021461,800 shares $7.50 million +5.2%3.0%5.6 $16.25 8/13/2021439,200 shares $6.25 million +10.8%2.9%5.4 $14.24 7/30/2021396,400 shares $5.73 million -43.4%2.6%4.6 $14.45 7/15/2021699,800 shares $10.93 million +3.8%4.6%9 $15.62 6/30/2021673,900 shares $11.65 million -10.4%4.4%8.6 $17.29 6/15/2021751,800 shares $13.53 million +5.8%5.0%8.8 $18.00 5/28/2021710,600 shares $11.75 million -4.1%4.7%7.5 $16.54 5/14/2021741,200 shares $12.93 million -1.6%4.9%6.9 $17.45 4/30/2021752,900 shares $14.26 million -2.1%5.0%6.3 $18.94 4/15/2021768,900 shares $14.33 million -1.9%5.1%6.1 $18.64 3/31/2021784,000 shares $14.89 million +9.4%5.3%5.5 $18.99 3/15/2021716,700 shares $14.23 million +6.3%4.9%4.1 $19.86 2/26/2021674,100 shares $12.62 million +5.7%4.7%3.1 $18.72 2/12/2021637,700 shares $13.09 million -0.3%4.5%3.2 $20.53 1/29/2021639,300 shares $11.62 million -35.8%4.5%3.3 $18.18 1/15/2021996,300 shares $18.39 million -2.3%7.0%5.4 $18.46 12/31/20201,020,000 shares $18.56 million +26.6%8.4%6 $18.20 12/15/2020805,800 shares $19.34 million +13.7%6.6%6.1 $24.00 11/30/2020708,700 shares $15.77 million +7.0%6.8%11.3 $22.25 11/15/2020662,600 shares $12.72 million +1.8%6.4%9.9 $19.19 10/30/2020650,900 shares $10.50 million +5.4%6.6%10.3 $16.13 10/15/2020617,700 shares $12.22 million -1.4%6.3%8.7 $19.78 9/30/2020626,400 shares $12.07 million +5.0%6.3%9 $19.27 9/15/2020596,700 shares $12.61 million -1.6%6.0%8.2 $21.14 8/31/2020606,300 shares $15.74 million +4.3%6.1%7.6 $25.96 8/14/2020581,600 shares $14.06 million -4.2%5.9%6.4 $24.17Truth about Trump you’ve never heard (Ad)Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here. 7/31/2020607,300 shares $13.41 million -6.7%6.1%6.4 $22.08 7/15/2020650,700 shares $12.33 million +2.0%6.5%7.5 $18.95 6/30/2020637,800 shares $12.41 million +17.2%6.4%7.5 $19.46 6/15/2020544,000 shares $9.58 million +0.7%5.4%6.8 $17.61 5/29/2020540,200 shares $9.04 million -0.9%5.4%6.6 $16.74 5/15/2020545,100 shares $9.39 million +1.9%5.5%8.2 $17.23 4/30/2020535,200 shares $9.18 million +3.2%5.1%8.2 $17.16 4/15/2020518,600 shares $7.66 million -1.2%4.9%7 $14.78 3/31/2020525,100 shares $8.09 million -15.0%4.9%4.4 $15.41 3/13/2020617,900 shares $9.11 million -4.3%5.8%9.5 $14.75 2/28/2020645,300 shares $7.03 million +5.7%6.1%1.8 $10.89 2/14/2020610,400 shares $7.88 million +27.1%5.7%1.7 $12.91 1/31/2020480,100 shares $7.94 million +20.1%5.3%1.3 $16.54 1/15/2020399,800 shares $6.87 million +48.7%4.4%1.1 $17.19 12/31/2019268,800 shares $4.71 million +139.4%3.0%0.8 $17.54 MIRM Short Interest - Frequently Asked Questions What is Mirum Pharmaceuticals' current short interest? Short interest is the volume of Mirum Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 8,500,000 shares of MIRM short. Learn More on Mirum Pharmaceuticals' current short interest. What is a good short interest ratio for Mirum Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MIRM shares currently have a short interest ratio of 17.0. Learn More on Mirum Pharmaceuticals's short interest ratio. Is Mirum Pharmaceuticals' short interest increasing or decreasing? Mirum Pharmaceuticals saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 8,500,000 shares, a drop of 0.9% from the previous total of 8,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mirum Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Mirum Pharmaceuticals: Prothena Co. plc (12.55%), MannKind Co. (13.13%), Day One Biopharmaceuticals, Inc. (18.47%), ANI Pharmaceuticals, Inc. (1.10%), AbCellera Biologics Inc. (11.31%), Collegium Pharmaceutical, Inc. (21.78%), Gyre Therapeutics, Inc. (0.54%), Arcutis Biotherapeutics, Inc. (18.74%), Belite Bio, Inc (0.06%), Enliven Therapeutics, Inc. (18.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Mirum Pharmaceuticals stock? Short selling MIRM is an investing strategy that aims to generate trading profit from Mirum Pharmaceuticals as its price is falling. MIRM shares are trading down $0.75 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mirum Pharmaceuticals? A short squeeze for Mirum Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MIRM, which in turn drives the price of the stock up even further. How often is Mirum Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MIRM, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Prothena Short Interest Data MannKind Short Interest Data Day One Biopharmaceuticals Short Interest Data ANI Pharmaceuticals Short Interest Data AbCellera Biologics Short Interest Data Collegium Pharmaceutical Short Interest Data Gyre Therapeutics Short Interest Data Arcutis Biotherapeutics Short Interest Data Belite Bio Short Interest Data Enliven Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MIRM) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBuy this small stock before coming AI Tidal WaveChaikin Analytics**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts41 banks launch ‘crypto dollar’Stansberry ResearchThe #1 Crypto for AIWeiss RatingsNew Options need New Trading StrategiesNetpicksWrite this ticker symbol down…StocksToTradeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders